Your browser doesn't support javascript.
loading
Presentation of ichthyosis after substrate reduction therapy in Gaucher type 1.
Herbster, Jack; Prada, Carlos E; Rasmussen, Carly A; Quadri, Allegra; Kuritza, Victoria; Viglione, Michael; Hoyer, Sheryl.
Afiliação
  • Herbster J; Biological Sciences Division, The University of Chicago, Chicago, Illinois, USA.
  • Prada CE; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Rasmussen CA; Division of Genetics, Genomics & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Quadri A; Division of Genetics, Genomics & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Kuritza V; Division of Genetics, Genomics & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Viglione M; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Hoyer S; PRW Laboratories, Charlottesville, Virginia, USA.
Am J Med Genet A ; : e63835, 2024 Aug 05.
Article em En | MEDLINE | ID: mdl-39101525
ABSTRACT
We describe a case in which a type 1 Gaucher patient developed ichthyosis weeks after starting substrate reduction therapy (SRT) with eliglustat. There are no reports of ichthyosis in the literature in enzyme replacement or SRT for Gaucher disease. Ichthyosis is seen with type 2 and 3 Gaucher disease, but not type 1. This raises the question Why would a patient develop ichthyosis after starting SRT?
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article